Fundies.
English

INVIVO THERAPEUTICS HOLDINGS CORP.

EDGAR
NVIV Current report (8-K) · filed 2024-01-03

97 filing records in this dataset, filed from 2005-11-10 to 2024-01-03. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist
Cash and cash equivalents
8.58 million Unit_Standard_USD_WOTOuhdDnkq8Rh6dfc4lug Source
Exact value

8581000 Unit_Standard_USD_WOTOuhdDnkq8Rh6dfc4lug

Long-term debt including current maturities
Not available
Shares outstanding
3.11 million Unit_Standard_shares_-azhpiQW_kmDy_PLbQLogA Source
Exact value

3105446 Unit_Standard_shares_-azhpiQW_kmDy_PLbQLogA

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-01-03.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 2 of 11 periods available· newest 2022-12-31
  • Net income: 2 of 11 periods available· newest 2022-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2022-12-31
  • Total assets: Multiple units; comparison withheld· newest 2022-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2022-12-31
  • Current assets: Multiple units; comparison withheld· newest 2022-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2022-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2022-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: Multiple units; comparison withheld· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 605,000

    Prior period

    −Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 9.9 million

    –

    Current period

    −Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 10.5 million

    –

    Exact inputs and evidence

    -10500000 − -9895000 = -605000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

    -9895000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -10500000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 1.63 million

    Prior period

    −Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 8.85 million

    –

    Current period

    −Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 10.48 million

    –

    Exact inputs and evidence

    -10482000 − -8854000 = -1628000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

    -8854000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -10482000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +107.8%

    Prior period

    Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 77,000

    –

    Current period

    Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 160,000

    –

    Exact inputs and evidence

    160000 − 77000 = 83000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

    77000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    160000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-01 – 2021-12-31
−Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 9.9 million
Exact value

Exact value: -9895000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

2021-01-01 – 2021-12-31: -9895000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 8.85 million
Exact value

Exact value: -8854000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

2021-01-01 – 2021-12-31: -8854000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 77,000
Exact value

Exact value: 77000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

2021-01-01 – 2021-12-31: 77000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 8.93 million
Calculation and evidence

-8854000 − 77000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

Exact free cash flow: -8931000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 10.5 million
Exact value

Exact value: -10500000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

2022-01-01 – 2022-12-31: -10500000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 10.48 million
Exact value

Exact value: -10482000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

2022-01-01 – 2022-12-31: -10482000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 160,000
Exact value

Exact value: 160000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

2022-01-01 – 2022-12-31: 160000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg 10.64 million
Calculation and evidence

-10482000 − 160000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

Exact free cash flow: -10642000 Unit_Standard_USD_-H8BdDbbYU2TRzOXrK2_qg

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

97 filings · 3,919 latest values · 3,919 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001292519, 1292519, NVIV, edgar:1292519

Also known as Design Source, Inc., INVIVO THERAPEUTICS HOLDINGS CORP., InVivo Therapeutics Holdings Corp.